The Journal of Practical Medicine ›› 2025, Vol. 41 ›› Issue (13): 2004-2010.doi: 10.3969/j.issn.1006-5725.2025.13.009
• Clinical Research • Previous Articles
Zhiqing XIAO1,2,Xue WU1,2,3,Rui QIU1,2,3,Jinghan CHI4,Shaodong HUA4,Bin ZHU4,De CHANG1,2()
Received:
2025-01-25
Online:
2025-07-10
Published:
2025-07-18
Contact:
De CHANG
E-mail:changde@301hospital.com.cn
CLC Number:
Zhiqing XIAO,Xue WU,Rui QIU,Jinghan CHI,Shaodong HUA,Bin ZHU,De CHANG. Construction and verification of multi⁃factor prediction model for refractory mycoplasma pneumoniae pneumonia in children[J]. The Journal of Practical Medicine, 2025, 41(13): 2004-2010.
Tab.1
Comparison of demographic and clinical characteristics of children in the GMPP and RMPP groups"
项目 | 总数(n = 282) | GMPP组(n = 163) | RMPP组(n = 119) | χ2/Z值 | P值 |
---|---|---|---|---|---|
性别 | |||||
女 | 146(51.8) | 81(49.7) | 65(54.6) | 0.669 | 0.413 |
男 | 136(48.2) | 82(50.3) | 54(45.4) | ||
年龄[M(P25,P75)]/岁 | 7.00(6.00,9.00) | 7.00(5.00,9.00) | 8.00(6.00,10.00) | -1.809 | 0.070 |
发热时间[M(P25,P75)]/d | 8.00(6.00,11.25) | 8.00(6.00,10.00) | 10.00(6.00,15.00) | -3.104 | 0.002 |
住院时间[M(P25,P75)]/d | 9.00(7.00,12.25) | 10.00(7.00,12.00) | 9.00(7.00,13.00) | -0.564 | 0.573 |
症状 | |||||
发热 | 275(97.5) | 158(96.9) | 117(98.3) | 0.124 | 0.725 |
咳嗽 | 275(97.5) | 156(95.7) | 119(100.0) | 3.617 | 0.057 |
咳痰 | 188(66.7) | 110(67.5) | 78(65.5) | 0.116 | 0.733 |
鼻塞 | 8(2.8) | 5(3.1) | 3(2.5) | 0 | 1.000 |
流涕 | 14(5.0) | 8(4.9) | 6(5.0) | 0.003 | 0.959 |
呕吐 | 14(5.0) | 9(5.5) | 5(4.2) | 0.254 | 0.614 |
喘息 | 9(3.2) | 7(4.3) | 2(1.7) | 0.793 | 0.217 |
呼吸困难 | 3(1.1) | 0(0) | 3(2.5) | 2.104 | 0.147 |
皮疹 | 9(3.2) | 5(3.1) | 4(3.4) | 0 | 1.000 |
肺部啰音 | 101(35.8) | 61(37.4) | 40(33.6) | 0.434 | 0.510 |
BMI[M(P25,P75)]/(kg/m2) | 15.58(14.41,17.82) | 15.43(14.06,18.07) | 15.97(14.78,17.69) | -1.601 | 0.109 |
并发症 | |||||
肝损害 | 6(2.1) | 5(3.1) | 1(0.8) | 0.743 | 0.389 |
心肌损害 | 10(3.5) | 2(1.2) | 8(6.7) | 4.573 | 0.032 |
凝血功能异常 | 10(3.5) | 2(1.2) | 8(6.7) | 4.573 | 0.032 |
心包积液 | 5(1.8) | 2(1.2) | 3(2.5) | 0.127 | 0.722 |
肺栓塞 | 1(0.4) | 0(0) | 1(0.8) | 0.422 |
Tab.2
Comparison of laboratory test results between the GMPP and RMPP groups"
项目 | 总数(n = 282) | GMPP组(n = 163) | RMPP组(n = 119) | Z/t值 | P值 |
---|---|---|---|---|---|
WBC/(×109/L) | 7.18(5.59,8.93) | 7.01(5.63,8.61) | 7.55(5.08,9.63) | -0.507 | 0.612 |
NEUT/(×109/L) | 4.10(3.00,5.50) | 4.00(3.00,5.50) | 4.20(2.75,5.55) | -0.076 | 0.939 |
LYMPH/(×109/L) | 2.10(1.70,2.90) | 2.10(1.73,2.88) | 2.10(1.60,2.90) | -0.603 | 0.546 |
EO/(×109/L) | 0.10(0,0.20) | 0.10(0,0.20) | 0.10(0,0.20) | -0.620 | 0.535 |
Hb(x ± s)/(g/L) | 125.70 ± 9.59 | 126.59 ± 9.44 | 124.46 ± 9.70 | 1.839 | 0.067 |
PLT/(×109/L) | 323.50(252.00,400.00) | 319.00(252.00,400.00) | 328.00(250.50,400.00) | -0.048 | 0.962 |
CRP/(mg/L) | 7.00(2.28,15.30) | 4.90(1.30,14.00) | 7.10(4.2,16.90) | -3.660 | 0.001 |
ESR/(mm/h) | 31.00(19.00,46.00) | 30.00(17.50,43.00) | 37.50(21.25,55.50) | -1.360 | 0.174 |
PCT/(μg/L) | 0.06(0.04,0.12) | 0.05(0.04,0.09) | 0.09(0.04,0.16) | -2.941 | 0.003 |
ALT/(U/L) | 13.00(10.10,19.00) | 13.00(10.80,18.00) | 13.00(9.40,22.00) | -0.508 | 0.612 |
AST/(U/L) | 22.00(18.03,27.00) | 22.00(18.70,27.50) | 22.00(18.00,27.00) | -0.771 | 0.441 |
T-BIL/(μmol/L) | 5.49(4.00,7.28) | 5.70(4.10,7.64) | 5.25(3.90,6.73) | -1.848 | 0.065 |
Alb(x ± s)/(g/L) | 40.12 ± 3.52 | 40.80 ± 3.21 | 39.16 ± 3.72 | 3.921 | 0.001 |
BUN/(mmol/L) | 3.44(2.64,4.20) | 3.40(2.64,4.19) | 3.50(2.62,4.20) | -0.576 | 0.565 |
Cr/(μmol/L) | 40.35(34.00,47.00) | 40.55(35.00,47.23) | 39.80(33.00,45.75) | -0.950 | 0.342 |
LDH/(U/L) | 267.50(240.00,311.75) | 263.00(236.00,303.00) | 273.00(240.00,317.00) | -2.074 | 0.038 |
CK-MB/(μg/L) | 16.20(13.43,20.10) | 16.20(13.10,19.50) | 16.20(13.55,20.50) | -0.476 | 0.634 |
IL-2/(pg/mL) | 2.82(1.26,4.62) | 2.17(1.03,4.25) | 3.44(1.70,5.22) | -2.335 | 0.020 |
IL-4/(pg/mL) | 3.17(1.68,5.00) | 3.14(1.58,4.99) | 3.22(1.80,5.02) | -0.287 | 0.774 |
TNF-α/(pg/mL) | 2.54(1.55,3.73) | 2.37(1.51,3.72) | 2.74(1.72,3.78) | -0.807 | 0.420 |
IL-10/(pg/mL) | 6.29(3.71,9.89) | 5.85(3.49,9.44) | 6.87(4.27,10.70) | -1.668 | 0.095 |
IL-17/(pg/mL) | 10.98(5.93,17.80) | 14.37(7.13,21.27) | 8.16(4.69,13.24) | -3.020 | 0.003 |
IL-6/(pg/mL) | 28.78(16.10,51.46) | 30.52(21.32,56.00) | 20.69(12.76,44.67) | -2.246 | 0.025 |
IFN-γ/(pg/mL) | 10.91(6.51,20.42) | 11.53(7.39,20.66) | 9.35(5.56,19.75) | -1.042 | 0.298 |
IFN-α/(pg/mL) | 3.13(1.58,5.40) | 2.69(1.42,6.08) | 3.13(1.72,4.70) | -0.263 | 0.792 |
IL-5/(pg/mL) | 2.45(1.13,4.37) | 1.99(0.85,4.12) | 2.65(1.84,4.97) | -2.181 | 0.029 |
IL-8/(pg/mL) | 28.86(16.14,46.21) | 25.45(15.16,43.25) | 32.99(21.26,59.58) | -1.983 | 0.047 |
IL-12P70/(pg/mL) | 2.52(0.87,5.57) | 2.13(0.57,5.25) | 2.59(1.49,5.64) | -0.996 | 0.319 |
IL-1β/(pg/mL) | 2.27(1.19,3.79) | 1.97(1.03,3.73) | 2.97(1.51,3.90) | -2.535 | 0.011 |
PT/s | 12.40(11.70,13.05) | 12.35(11.60,12.90) | 12.50(11.70,13.30) | -1.374 | 0.169 |
APTT/s | 32.00(29.65,33.85) | 31.90(29.43,34.03) | 32.20(30.05,33.80) | -0.661 | 0.508 |
FIB(x ± s)/(g/L) | 3.41 ± 0.61 | 3.38 ± 0.55 | 3.45 ± 0.66 | -0.740 | 0.460 |
TT(x ± s)/s | 14.33 ± 1.13 | 14.34 ± 1.03 | 14.32 ± 1.25 | 0.135 | 0.893 |
D-dimer/(mg/L) | 0.20(0.12,0.32) | 0.18(0.13,0.29) | 0.24(0.14,0.50) | -2.101 | 0.036 |
Tab.3
Comparison of lung CT results between the GMPP and RMPP groups"
项目 | 总数(n = 282) | GMPP组(n = 163) | RMPP组(n = 119) | χ2 值 | P值 |
---|---|---|---|---|---|
磨玻璃影 | 61(21.6) | 31(19.0) | 30(25.2) | 1.556 | 0.212 |
斑片影 | 213(75.5) | 128(78.5) | 85(71.4) | 1.876 | 0.171 |
结节影 | 21(7.4) | 10(6.1) | 11(9.2) | 0.964 | 0.326 |
实变影 | 166(58.9) | 87(53.4) | 79(66.4) | 4.810 | 0.028 |
索条影 | 55(19.5) | 31(19.0) | 24(20.2) | 0.058 | 0.810 |
充气支气管征 | 77(27.3) | 43(26.4) | 34(28.6) | 0.166 | 0.683 |
胸腔积液 | 33(11.7) | 11(6.7) | 22(18.5) | 9.173 | 0.002 |
肺不张 | 40(14.2) | 17(10.4) | 23(19.3) | 4.474 | 0.039 |
Tab.4
Univariate and multivariate logistic regression analysis of risk factors for RMPP in children"
项目 | β | P值 | OR(95%CI) | β | P值 | OR(95%CI) |
---|---|---|---|---|---|---|
发热时长 | 0.080 | 0.001 | 1.083(1.036,1.133) | |||
CRP | 0.013 | 0.062 | 1.013(0.999,1.027) | -0.066 | 0.010 | 0.936(0.891 ~ 0.985) |
PCT | 1.392 | 0.085 | 4.023(0.826,19.593) | |||
T-BIL | -0.083 | 0.096 | 0.920(0.834,1.015) | -0.343 | 0.025 | 0.710(0.526 ~ 0.958) |
LDH | 0.004 | 0.023 | 1.004(1.001,1.008) | 0.012 | 0.013 | 1.012(1.003 ~ 1.022) |
IL-2 | 0.117 | 0.036 | 1.124(1.007,1.254) | |||
IL-17 | -0.033 | 0.053 | 0.968(0.937,1.000) | -0.120 | 0.004 | 0.887(0.817 ~ 0.962) |
IL-1β | 0.116 | 0.083 | 1.123(0.985,1.280) | |||
PT | 0.251 | 0.089 | 1.286(0.962,1.718) | 0.785 | 0.028 | 2.192(1.087 ~ 4.421) |
心肌损伤 | 1.758 | 0.028 | 5.802(1.209,27.838) | |||
胸腔积液 | 1.142 | 0.004 | 3.134(1.455,6.750) |
[1] |
MEYER SAUTEUR P M, UNGER W W J, VAN ROSSUM A M C, et al. The Art and Science of Diagnosing Mycoplasma pneumoniae Infection[J]. Pediatr Infect Dis J, 2018, 37(11): 1192-1195. doi:10.1097/inf.0000000000002171
doi: 10.1097/inf.0000000000002171 |
[2] |
WAITES K B, XIAO L, LIU Y, et al. Mycoplasma pneumoniae from the Respiratory Tract and Beyond[J]. Clin Microbiol Rev, 2017, 30(3): 747-809. doi:10.1128/cmr.00114-16
doi: 10.1128/cmr.00114-16 |
[3] | 许颖, 苏艳琦, 郎会利. 肺炎支原体肺炎患儿血清维生素A与维生素E水平调查[J].中国中西医结合儿科学, 2019, 11(4): 351-353. |
[4] |
方俊梅, 包晓珍. 丙种球蛋白辅助治疗儿童难治性肺炎支原体肺炎的临床疗效[J].中国中西医结合儿科学, 2020, 12(3): 233-236. doi:10.3969/j.issn.1674-3865.2020.03.014
doi: 10.3969/j.issn.1674-3865.2020.03.014 |
[5] |
赵顺英, 钱素云, 陈志敏, 等. 儿童肺炎支原体肺炎诊疗指南(2023年版)[J].传染病信息, 2023, 36(4): 291-297. doi:10.12372/jcp.2023.22e0475
doi: 10.12372/jcp.2023.22e0475 |
[6] | 王亨, 赵顺英. 儿童难治性肺炎支原体肺炎的发病机制和诊治研究进展[J].世界临床药物, 2020, 41(5): 389-398. |
[7] | 鲍汝英, 徐国成. 儿童难治性肺炎支原体肺炎的发病机制及治疗进展[J].齐齐哈尔医学院学报, 2022, 43(13): 1274-1278. |
[8] |
刘帅帅, 马静, 张忠晓, 等. 儿童肺炎支原体坏死性肺炎的早期预测指标[J].中华实用儿科临床杂志, 2021(8): 601-604. doi:10.3760/cma.j.cn101070-20191231-01327
doi: 10.3760/cma.j.cn101070-20191231-01327 |
[9] |
JIANG Z, LI S, ZHU C, et al. Mycoplasma pneumoniae Infections: Pathogenesis and Vaccine Development[J]. Pathogens, 2021, 10(2):119. doi:10.3390/pathogens10020119
doi: 10.3390/pathogens10020119 |
[10] |
CHOI Y J, CHUNG E H, LEE E, et al. Clinical Characteristics of Macrolide-Refractory Mycoplasma pneumoniae Pneumonia in Korean Children: A Multicenter Retrospective Study[J]. J Clin Med, 2022, 11(2):306. doi:10.3390/jcm11020306
doi: 10.3390/jcm11020306 |
[11] |
ZHANG Y, ZHOU Y, LI S, et al. The Clinical Characteristics and Predictors of Refractory Mycoplasma pneumoniae Pneumonia in Children[J]. PLoS One, 2016, 11(5): e0156465. doi:10.1371/journal.pone.0156465
doi: 10.1371/journal.pone.0156465 |
[12] |
KAWAMATA R, YOKOYAMA K, SATO M, et al. Utility of serum ferritin and lactate dehydrogenase as surrogate markers for steroid therapy for Mycoplasma pneumoniae pneumonia[J]. J Infect Chemother, 2015, 21(11): 783-789. doi:10.1016/j.jiac.2015.07.009
doi: 10.1016/j.jiac.2015.07.009 |
[13] |
JIANG Y, WANG W, ZHANG Z, et al. Serum amyloid a, C-reactive protein, and procalcitonin levels in children with Mycoplasma pneumoniae infection[J]. J Clin Lab Anal, 2022, 36(3): e24265. doi:10.1002/jcla.24265
doi: 10.1002/jcla.24265 |
[14] |
JIN H L, ZHAN L, MEI S F, et al. Serum Cytokines and FeNO in School-Aged Children with Mycoplasma pneumoniae Pneumonia[J]. Med Sci Monit, 2020, 26: e923449. doi:10.12659/msm.923449
doi: 10.12659/msm.923449 |
[15] |
YU M, ZHANG Q, YAN H. Cytokines and refractory mycoplasma pneumoniae pneumonia in children: a systematic review[J]. Minerva Pediatr (Torino), 2024, 76(2): 259-267. doi:10.23736/s2724-5276.23.07158-6
doi: 10.23736/s2724-5276.23.07158-6 |
[16] |
FAN F, LV J, YANG Q, et al. Clinical characteristics and serum inflammatory markers of community-acquired mycoplasma pneumonia in children[J]. Clin Respir J, 2023, 17(7): 607-617. doi:10.1111/crj.13620
doi: 10.1111/crj.13620 |
[17] |
FAN H, LU B, YANG D, et al. Distribution and Expression of IL-17 and Related Cytokines in Children with Mycoplasma pneumoniae Pneumonia[J]. Jpn J Infect Dis, 2019, 72(6): 387-393. doi:10.7883/yoken.jjid.2019.113
doi: 10.7883/yoken.jjid.2019.113 |
[18] |
LI T, YU H, HOU W, et al. Evaluation of variation in coagulation among children with Mycoplasma pneumoniae pneumonia: a case-control study[J]. J Int Med Res, 2017, 45(6): 2110-2118. doi:10.1177/0300060517709613
doi: 10.1177/0300060517709613 |
[19] |
ZHOU Y, WANG J, CHEN W, et al. Impact of viral coinfection and macrolide-resistant mycoplasma infection in children with refractory Mycoplasma pneumoniae pneumonia[J]. BMC Infect Dis, 2020, 20(1): 633. doi:10.1186/s12879-020-05356-1
doi: 10.1186/s12879-020-05356-1 |
[1] | Runfang WANG,Ya DUAN,Liyan DU,Xiaodan LIU,Wenning LIAN,Yan HUO,Dandan. YANG. Epidemiological status and risk factors associated with placental abruption among pregnant women in Hebei Province [J]. The Journal of Practical Medicine, 2025, 41(6): 904-910. |
[2] | Dongli LIU,Zilin QUAN,Lingxiu ZHONG,Qiqi CHEN,Wenqiao CAI,Senpei ZHUANG,Ying WEI,Huiyi PAN,Yawen. LIN. Construction and validation of a predictive model for antibiotic-associated diarrhea after surgery in children with congenital heart disease [J]. The Journal of Practical Medicine, 2025, 41(5): 683-690. |
[3] | Qiaoying MO,Fangyi ZHU,Cunkui ZHU,Shenglong. MA. Nomogram model of malnutrition risk in patients suffering from chronic heart failure grounded on GNRI score [J]. The Journal of Practical Medicine, 2025, 41(5): 691-698. |
[4] | Shulian GAO,Lingxiu ZHONG,Yamin SONG,Lixia LIN,Senpei ZHUANG,Jian TAO. Risk factors of tracheal reintubation after total aortic arch replacement [J]. The Journal of Practical Medicine, 2025, 41(11): 1681-1686. |
[5] | Qiannan JIANG,Tingting LIU,Yingying LIU,Kaijie CUI,Xiuxiang. LIU. Patent ductus arteriosus severity predicts the occurrence and mortality of pulmonary hemorrhage in premature infants with gestational age ≤ 32 weeks [J]. The Journal of Practical Medicine, 2025, 41(10): 1575-1583. |
[6] | Qingqing WANG,Jie DING,Haiwen LI,Zhijian DONG,Yiying WANG,Siqi LIU,Guoji CHANG,Lijuan HUA,Huayi CHEN,Shenghao LI,Yongrui. YANG. Analysis of factors influencing short⁃term adverse clinical outcome in cirrhotic patients with grade 2/3 ascites [J]. The Journal of Practical Medicine, 2024, 40(8): 1114-1120. |
[7] | Xiaotong LIU,Xianhua SU,Zhijun XIN,Fengqiong GAO,Jiayi FENG,Tongxia. XIA. Risk factors of postoperative complications in patients with spinal tuberculosis and the predictive value of prognostic nutritional index [J]. The Journal of Practical Medicine, 2024, 40(7): 972-978. |
[8] | Changzhi GUO,Tao SUN,Shuman HAN,Lingxiang WANG,Mengjing. NIU. Risk factors of peripheral infections of knee joint tumor prosthesis and predictive value of serum D⁃dimer and TLR2 [J]. The Journal of Practical Medicine, 2024, 40(6): 814-819. |
[9] | Xilin WANG,Chanjuan YANG,Daomeng. CHENG. Construction of a nomogram prediction model for aggressive behavior in patients with bipolar disorder [J]. The Journal of Practical Medicine, 2024, 40(5): 677-681. |
[10] | Huiqun WANG,Chao YE,Chao XU,Si CHEN,Kaiguang ZHANG,Mei. XIAO. A 5⁃year follow⁃up study of rebleeding after endoscopic treatment of esophageal gastric varices rebleeding associated with liver cirrhosis [J]. The Journal of Practical Medicine, 2024, 40(22): 3155-3159. |
[11] | Shijun LUO,Lizi ZHANG,Dunjin. CHEN. Diagnosis, prevention and treatment of placenta accreta spectrum with non⁃traumatic factors [J]. The Journal of Practical Medicine, 2024, 40(21): 2971-2975. |
[12] | Lili TANG,Xueming LI,Liming LEI,Xiaodong ZENG,Yun LING,Qiongyu LIN,Sumin. ZHU. Risk factors for prolonged ICU stay after surgery in patients with infective endocarditis [J]. The Journal of Practical Medicine, 2024, 40(20): 2854-2859. |
[13] | Xianghong CHEN,Xiumin CHEN,Yingyan ZHOU,Li LI,Zhenxiong. XU. Advancements in the investigation of cardiovascular risk associated with idiopathic inflammatory myopathy [J]. The Journal of Practical Medicine, 2024, 40(19): 2801-2805. |
[14] | Jun ZHENG,Qiye WU,Xia ZENG,Zhixian LEI,Dufei. ZHANG. Clinical characteristics and risk factors of the occurrence of hypoxic hepatitis in children with shock [J]. The Journal of Practical Medicine, 2024, 40(15): 2126-2132. |
[15] | Lanrong WANG,Xiaocui WANG,Yang CAO,Rui LI,Weihong WANG,Yingxi XU,Weixiang SHI,Yufei YANG,Ke MENG,Wei. ZHANG. A cross⁃sectional study on the risk of early screening for lung cancer in Zhengzhou City [J]. The Journal of Practical Medicine, 2024, 40(15): 2154-2160. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||